TDP-43 plasma levels are higher in amyotrophic lateral sclerosis

Amyotrophic Lateral Sclerosis

Volumn 13, Issue 5, 2012, Pages 446-451

  Verstraete, Esther ^a   Kuiperij, H Bea ^b,c   Van Blitterswijk, Marka M ^a   Veldink, Jan H ^a   Schelhaas, H Jurgen ^b   Van Den Berg, Leonard H ^a   Verbeek, Marcel M ^b,c  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Department of Neurology ^*  (Netherlands)

^c RADBOUD UNIVERSITY   (Netherlands)

Author keywords

Amyotrophic lateral sclerosis; Biomarker; ELISA; Plasma; TAR DNA binding protein of 43 kDa (TDP 43)

Indexed keywords

TAR DNA BINDING PROTEIN;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CEREBROSPINAL FLUID; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXON; FEMALE; GENE MUTATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; AMYOTROPHIC LATERAL SCLEROSIS; BIOLOGICAL MARKERS; BRAIN; DNA-BINDING PROTEINS; FEMALE; HUMANS; MALE; MIDDLE AGED; MUTATION; YOUNG ADULT;

EID: 84865337487     PISSN: 17482968     EISSN: 1471180X     Source Type: Journal    
DOI: 10.3109/17482968.2012.703208     Document Type: Article

References (19)

1. Hardiman O, van den Berg LH, Kiernan MC. Clinical diagnosis and management of amyotrophic lateral sclerosis. Nat Rev Neurol. 2011; 7: 639-49.
2. Ringholz GM, Appel SH, Bradshaw M, Cooke NA, Mosnik DM, Schulz PE. Prevalence and patterns of cognitive impairment in sporadic ALS. Neurology. 2005; 65: 586-90.
3. Lillo P, Garcin B, Hornberger M, Bak TH, Hodges Jr. Neurobehavioural features in frontotemporal dementia with amyotrophic lateral sclerosis. Arch Neurol. 2010; 67: 826-30.
4. Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006; 314: 130-3.
5. Mackenzie IR, Rademakers R, Neumann M. TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia. Lancet Neurol. 2010; 9: 995-1007.
6. Kabashi E, Valdmanis PN, Dion P, Spiegelman D, McConkey BJ, Vande Velde C, et al. TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat Genet. 2008; 40: 572-4.
7. Sreedharan J, Blair IP, Tripathi VB, Hu X, Vance C, Rogelj B, et al. TDP-43 mutations in familial and sporadic amyo-trophic lateral sclerosis. Science. 2008; 319: 1668-72.
8. Daoud H, Valdmanis PN, Kabashi E, Dion P, Dupre N, Camu W, et al. Contribution of TARDBP mutations to sporadic amyotrophic lateral sclerosis. J Med Genet. 2009;46: 112-4.
9. Ticozzi N, LeClerc AL, van Blitterswijk M, Keagle P, McKenna-Yasek DM, Sapp PC, et al. Mutational analysis of TARDBP in neurodegenerative diseases. Neurobiol Aging. 2011; 32: 2096-9.
10. Foulds P, McAuley E, Gibbons L, Davidson Y, Pickering-Brown SM, Neary D, et al. TDP-43 protein in plasma may index TDP-43 brain pathology in Alzheimer ' s disease and frontotemporal lobar degeneration. Acta Neuropathol. 2008; 116: 141-6.
11. Foulds PG, Davidson Y, Mishra M, Hobson DJ, Humphreys KM, Taylor M, et al. Plasma phosphorylated-TDP-43 protein levels correlate with brain pathology in frontotemporal lobar degeneration. Acta Neuropathol. 2009; 118: 647-58.
12. Brooks BR, Miller RG, Swash M, Munsat TL, World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2000; 1: 293-9.
13. Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 1998; 51: 1546-54.
14. Kasai T, Tokuda T, Ishigami N, Sasayama H, Foulds P, Mitchell DJ, et al. Increased TDP-43 protein in cerebrospi-nal fl uid of patients with amyotrophic lateral sclerosis. Acta Neuropathol. 2009; 117: 55-62.
15. Nickerson DA, Tobe VO, Taylor SL. PolyPhred: automating the detection and genotyping of single nucleotide substitutions using fl uorescence-based resequencing. Nucleic Acids Res. 1997; 25: 2745-51.
16. Kuiperij HB, Abdo WF, van Engelen BG, Schelhaas HJ, Verbeek MM. TDP-43 plasma levels do not differentiate sporadic inclusion body myositis from other infl ammatory myopathies. Acta Neuropathol. 2010; 120: 825-6.
17. Steinacker P, Hendrich C, Sperfeld AD, Jesse S, von Arnim CA, Lehnert S, et al. TDP-43 in cerebrospinal fl uid of patients with frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Arch Neurol. 2008; 65: 1481-7.
18. Noto Y, Shibuya K, Sato Y, Kanai K, Misawa S, Sawai S, et al. Elevated CSF TDP-43 levels in amyotrophic lateral sclerosis: specifi city, sensitivity, and a possible prognostic value. Amyotroph Lateral Scler. 2011; 12: 140-3.
19. Ghidoni R, Benussi L, Glionna M, Franzoni M, Binetti G. Low plasma progranulin levels predict progranulin mutations in frontotemporal lobar degeneration. Neurology. 2008; 71: 1235-9.